Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Background<p>Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor prognosis. Efferocytosis, an essential process for clearing apoptotic cells, is involved in shaping immunosuppressive microenvironment, facilitating tumor immune evasion. This study aims to evaluate the...

Полное описание

Сохранить в:

Библиографические подробности
Главный автор:	Xiangjun Wang (2522917) (author)
Другие авторы:	Wei Wang (17594) (author), Chuanxin Yang (18266948) (author), Puxiongzhi Wang (3877201) (author), Yangming Liu (12254459) (author), Liqin Yu (1461880) (author), Sijie Zhang (7429373) (author), Xiaoyu Yan (500545) (author), Jian Wang (5901) (author)
Опубликовано:	2025
Предметы:	Genetic Immunology pancreatic ductal adenocarcinoma efferocytosis prognostic signature immunosuppressive microenvironment P2RY6 MRS-2578
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 5_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Image 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
по: Xiangjun Wang (2522917)
Опубликовано: (2025)

Supplementary Data 1 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
по: Gregory L. Beatty (15087193)
Опубликовано: (2025)

Supplementary Data 2 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
по: Gregory L. Beatty (15087193)
Опубликовано: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
по: Marwa Zafarullah (12527002)
Опубликовано: (2025)

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx
по: Jichang Liu (1263291)
Опубликовано: (2025)

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
по: Jichang Liu (1263291)
Опубликовано: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
по: Jichang Liu (1263291)
Опубликовано: (2025)

Data Sheet 3_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.pdf
по: Ping Liao (5424887)
Опубликовано: (2025)

Data Sheet 1_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.docx
по: Ping Liao (5424887)
Опубликовано: (2025)

Data Sheet 2_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.xls
по: Ping Liao (5424887)
Опубликовано: (2025)

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx
по: Yanju Li (9697993)
Опубликовано: (2025)

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
по: Rui Wang (52434)
Опубликовано: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
по: Rui Wang (52434)
Опубликовано: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
по: Rui Wang (52434)
Опубликовано: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
по: Erika Y. Faraoni (14844897)
Опубликовано: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
по: Erika Y. Faraoni (14844897)
Опубликовано: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
по: Erika Y. Faraoni (14844897)
Опубликовано: (2025)

الإثبات بالتوقيع الرقمي في العقود الذكيّة باستخدام تقنية البلوك تشين بين الفقه الإسلامي وقانون المعاملات الإلكترونيّة الأردني وقانون البينات
по: Daoud, Hayel Abdel Hafeez Yousef
Опубликовано: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
по: Hailong Pang (12841991)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_qos6ckc3slt1o8ikff65865k48